p-mTOR、p-4EBP1及p-S6K1在结直肠腺癌组织中的表达及临床意义

doi:10.13418/j.issn.1001-165x.2022.5.08

Abstract

Abstract: Objective To study the expression of p-mTOR, p-4EBP1 and p-S6K1 in colorectal adenocarcinoma and adjacent tissues and analyze their relationship with relevant clinicopathological data, and explore their occurrence and development in colorectal adenocarcinoma and the possible role and clinical significance. Methods Immunohistochemistry was used to detect the expression of p-mTOR, p-4EBP1 and p-S6K1 in 60 cases of colorectal adenocarcinoma tissues and 40 cases of adjacent normal tissues, compare the differences of each group, and analyze their relationship with relevant clinicopathological characteristics. The positive rate correlation analysis was performed by Spearman correlation analysis, and the test level α=0.05. Results The expression levels of p-mTOR, p-4EBP1 and p-S6K1 in colorectal adenocarcinoma tissues were higher than those in adjacent tissues on average, with statistically significant differences (P<0.05). The expression of p-mTOR was related to the stage of patients with lymph node metastasis, TNM stage and differentiation degree (P<0.05). The expression of p-S6K1 was related to the TNM stage and differentiation degree of the patient (P<0.05). The expression of p-mTOR and p-4EBP1 in colorectal adenocarcinoma tissue has a certain positive correlation (P<0.05), and the expression of p-mTOR and p-S6K1 in colorectal adenocarcinoma tissue has a significant positive correlation (P<0.05). Conclusions The overexpression of p-mTOR, p-4EBP1 and p-S6K1 in the mucosal tissue of colorectal adenocarcinoma may be one of the important mechanisms for the occurrence of colorectal adenocarcinoma. These three phosphorylated proteins may be related to the occurrence and development of colorectal adenocarcinoma.

Key words: Nasopharyngeal carcinoma; , , Drug resistance; , , Micro RNA; , Cisplatin; , Cyclin protein

CLC Number:

R766.3

Cao Li, Chen Peng, Li Dingchang, Dong Guanglong. Expression and clinical significance of p-mTOR, p-4EBP1 and p-S6K1 in colorectal adenocarcinoma[J]. Chinese Journal of Clinical Anatomy, 2022, 40(5): 541-547.

References 20

[1]	中华人民共和国国家卫生健康委员会医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2020年版)[J]. 中国实用外科杂志, 2020, 40(6): 601-625. DOI: 10.19538/j.cjps.issn1005-2208.2020.06.01.
[2]	汤国辉, 贺修胜. 结直肠癌相关长链非编码RNA的研究进展[J]. 中南医学科学杂志, 2018, 46(3): 241-246. DOI: 10.15972/j.cnki.43-1509/r.2018.03.004.
[3]	Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism[J]. Cell, 2006, 124(3): 471-484. DOI: 10.1016/j.cell. 2006. 01.016.
[4]	Francipane MG, Lagasse E. mTOR pathway in colorectal cancer: an update[J]. Oncotarget, 2014, 5(1): 49-66. DOI: 10.18632/oncotarget. 1548.
[5]	Zhang YJ, Dai Q, Sun DF, et al. mTOR signaling patnway is a target for the treatment of colorectal cancer[J]. Ann Surg Oncol, 2009, 16(9): 2617-2628. DOI: 10.1245/s10434-009-0555-9.
[6]	Zhu Y, Jiang HG, Chen ZH, et al. Short-term efficacy of laparoscopic treatment for colorectal cancer in patients with schistosomiasis japonica[J]. Gastroenterol Res Pract, 2016, 2016: 8357025. DOI: 10.1155/2016/8357025.
[7]	O’Reilly KE, Rojo F, She QB, et al. mTOR inhibition induces upstream receptortyrosine kinase signaling and activates Akt[J]. Cancer Res, 2006, 66(3): 1500-1508. DOI: 10.1158/0008-5472.CAN-05-2925.
[8]	Wallin JJ, Edgar KA, Guan J, et al. GDC-0980 is a novel classⅠPI3K/mTOR kinase inhhibitor with robust activity in cancer models driven by the PI3K pathway[J]. Mol Cancer Ther, 2011, 10(12): 2426-2436. DOI: 10.1158/1535-7163.MCT-11-0446.
[9]	Maira SM, Stauffer F, Brueggen J, et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity[J]. Mol Cancer Ther, 2008, 7(7): 1851-1863. DOI: 10.1158/1535-7163.MCT-08-0017.
[10]	Dobbelstein M, Moll U. Targeting tumour-supportive cellular machineries in anticancer drug development[J]. Nat Rev Drug Discov, 2014, 13(3): 179-196. DOI: 10.1038/nrd4201.
[11]	Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth[J]. Nature, 2006, 441(7092): 424-430. DOI: 10.1038/nature04869.
[12]	Hay N, Sonenberg N. Upstream and downstream of mTOR[J]. Genes Dev, 2004, 18(16): 1926-1945. DOI: 10.1101/gad.1212704.
[13]	Beca F, Andre R, Martins DR, et al. p-mTOR expression is associated with better prognosis in luminal breast carcinoma[J]. J Clin Pathol, 2014, 67(11): 961-967. DOI: 10.1136/jclinpath-2014-202320.
[14]	Slattery ML, Herrick JS, Lundgreen A, et al. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: Mtor, PTEN, STK11, RPKAA1, PRKAG2, TSC1, PI3K, and Akt1[J]. Gareinogenesis, 2010, 39(1): 1604-1611. DOI: 10.1093/carcin/bgq142.
[15]	王茜, 时延龙, 毕经旺. p-mTOR与HIF-1α在结直肠癌组织中的表达及其临床意义[J]. 中国肿瘤生物治疗杂志, 2015, 22(6): 779-784. DOI: 10.3872/j.issn.1007-385X.2015.06.017.
[16]	赵长林, 胡芳娟, 曹红霞, 等. 直肠癌组织中mTOR和VEGF的表达与侵袭转移及预后的关系[J]. 临床肿瘤学杂志, 2012, 17(10): 899-903. DOI: 10.3969/j.issn.1009-0460.2012.10.008.
[17]	张毅, 张甘露, 王俊红, 等. 直肠癌组织Akt-mTOR蛋白表达与临床病理因素相关性分析[J]. 中华肿瘤防治杂志, 2013, 20(4): 296-300. DOI:CNKI:SUN:LCZL.0.2012-10-008.
[18]	West MG, Stoneley M, Willis AE, et al.Translation induction of the c-myc oncogene via activation of the FRAP/TOR signaling pathway[J]. Oncogene, 1998, 17(6): 769-780. DOI: 10.1038/sj.onc.1201990.
[19]	Populo H, Soares P, Faustino A, et al. mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics[J]. Pigment Cell Melanoma Res, 2011, 24(1): 254-257. DOI: 10.1111/j.1755-148X.2010.00796.x.
[20]	No JH, Jeon YT, Park IA, et al. Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer[J]. Gynecol Oncol,2011, 121(1):8-12. DOI: 10.1016/j.ygyno. 2010. 12.364.

Expression and clinical significance of p-mTOR, p-4EBP1 and p-S6K1 in colorectal adenocarcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 20

Related Articles 15

Metrics

Comments

Recommended 0

[1]	Jiang Jianhong, Duan Renpeng, Li Xiaofeng. Application of three-dimensional visualization technology in the anatomical variations of hilar bile ducts in Chinese population [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 1-4.
[2]	Guo Hongzhi, Wang Yu, Zhang Jiaqi, Liang Haibin, Ma Ziwei, Feng Wei, Wu You, Si Ziyi. Evaluation of placental vascular structure in preeclampsia by vascular casting combined with CT three-dimensional model [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 5-10.
[3]	Li Jiawei, Zhang Jing, Li Canran, Lan Wenjie, Ji Qingyu, Guo Zhiyong, Zhang Yunfeng, Liu Qi, Chen Qingwei, Li Xiaohe. X-ray measurement of proximal femur anatomical parameters in Mongolian population [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 11-16.
[4]	. Digital measurement and clinical significance of occipitocervical Angle and posterior occipitocervical Angle in children and adolescents [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 17-20.
[5]	Li Wen, Yang Siyi, Huang Lei, Qing Jiwen, Jiang Songtao, Zhang Lei. Morphological characteristics and clinical significance of Lisfranc ligament based on MRI [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 21-25.
[6]	Li Fanfan, Xu Yang, Wang Xiaoxu. Therapeutic effect of shikonin on the treatment of granuloma lobular mastitis in model rats by regulating Nrf2/HO-1 signaling pathway [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 26-32.
[7]	Wang Xinghang, Ding Jiayuan, Li Fang, Bao Cuifen, Yan Lijing. Ginsenoside Rg1 reduces the inflammatory response of microglia after oxygen glucose deprivation/resupply by inhibiting the NLRP3 inflammasome pathway [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 33-41.
[8]	Cheng Yingying, Wu Jianjun, Cai Haiyan , Jiao Xunwen, Ma Jiangbo, Ding Yinxiu. Activation and functional changes of astrocytes cultured in vitro under inflammatory stimulation [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 42-46.
[9]	Qi Zhi, Yang Li, Jia Qiuye, Chen Haolun, Duan Zhaoda, Wu Chunyun. Edaravone regulates Sirt3 expression in lipopolysaccharide-activated microglia via MAPKs signaling pathway [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 47-53.
[10]	Zhang Jingjing, Wang Hongxin. Protective effect of Baicalin on rats with pulmonary hypertension through PDGF/P38 MAPK signaling pathway [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 54-58.
[11]	Yue Qin, Chen Rongli, Xiong Jingxi, Wang Tingyi, Cai Zhiheng, Yi Qiushi, Zeng Xinyi. Effect of Bletilla striata polysaccharides on the choke-area of cross-boundary flap in rats [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 59-64.
[12]	Li Xiaoyu , Zhang Lei , Fu Lei , Li Dongbo , Wang Guoyou. Finite element study on the treatment of Sanders type II calcaneal fracture with three-step reduction method [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 65-70.
[13]	Wu Yanfei, Ma Jianxiong, Lu Bin, Wang Ying, Bai Haohao, Jin Hongzhen, Ma Xinlong. Study on the correlation between the reconstruction of grayscale values using CT post-processing technology and the compressive strength of the endplate [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 71-76.
[14]	Zhuang Wanqiang, Tang Yi, Luo Yonggang, Zhang Hui. An early and mid-term retrospective study of the effects of arthroscopy combined with high tibial osteotomy on patellar position and patellofemoral joint function [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 77-82.
[15]	Luo Ying, Dou Weiyu, Wu Xiaohang, Chen Jingkun, Peng Changgui, Pan Jianying . Risk factors of postoperative complications of calcaneal fractures treated with hippocampal plate internal fixation through minimally invasive method [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 83-88.